Sources | Names Used |
---|---|
CTRPv2 | BRD9876:MK-1775 (4:1 mol/mol) |
PharmacoGx | BRD9876:MK-1775 (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ATAD5 | CTRPv2 | pan-cancer | AAC | 0.36 | 0.004 |
mRNA | NSRP1 | CTRPv2 | pan-cancer | AAC | -0.33 | 0.004 |
mRNA | FMR1 | CTRPv2 | pan-cancer | AAC | 0.31 | 0.004 |
mRNA | ZGRF1 | CTRPv2 | pan-cancer | AAC | 0.35 | 0.004 |
mRNA | PPP5C | CTRPv2 | pan-cancer | AAC | 0.34 | 0.004 |
mRNA | MDFIC | CTRPv2 | pan-cancer | AAC | -0.33 | 0.004 |
mRNA | CYBRD1 | CTRPv2 | pan-cancer | AAC | -0.41 | 0.004 |
mRNA | ZNF273 | CTRPv2 | pan-cancer | AAC | 0.35 | 0.004 |
mRNA | SLC16A1 | CTRPv2 | pan-cancer | AAC | 0.37 | 0.004 |
mRNA | DEFB132 | CTRPv2 | pan-cancer | AAC | -0.34 | 0.004 |